cellulitis_erysipelas%20(pediatric)
CELLULITIS/ERYSIPELAS (PEDIATRIC)
Cellulitis is an acute spreading skin infection that may go deep, involving the subcutaneous tissues.
It typically occurs in areas where the skin integrity has been compromised.
May result from blood-borne spread of infection to the skin and subcutaneous tissues.
It is commonly caused by beta-hemolytic streptococci and Staphylococcus aureus in adults and Haemophilus influenzae type B in patients <3 year of age.

Introduction

  • An acute spreading skin infection that may go deep, involving the subcutaneous tissues
  • Typically occurs in areas where the skin integrity has been compromised
  • May also result from blood-borne spread of infection to the skin & subcutaneous tissues

Definition

Erysipelas

  • A type of cellulitis w/ sharply demarcated margins involving the epidermis & superficial lymphatics
  • Onset of symptoms is acute whereas cellulitis has an indolent course
  • More commonly caused by beta-hemolytic streptococci

Etiology

  • Commonly caused by beta-hemolytic streptococci & Staphylococcus aureus in adults, & Haemophilus influenzae type B in patients <3 years
    • Infection due to streptococci is rapidly spreading because of streptokinase while that of staphylococci is localized
    • Consider Methicillin-resistant S aureus (MRSA) in patients w/ recurrent cellulitis, or refractory to treatment 

Uncomplicated cellulitis

  • Beta-hemolytic streptococcal etiology in 90% of infections but S aureus is difficult to exclude especially if mixed infection occurs

Complicated cellulitis

  • Group A streptococci, Staphylococcus aureus, H influenzae B, Enterobacteriaceae & anaerobes

Signs and Symptoms

  • Rapidly spreading area of acute inflammation of the dermis & subcutaneous tissue
  • Lymphangitis & inflammation of the regional lymph nodes may occur
  • Area is usually tender, erythematous & warm to the touch
  • Patient may have malaise, fever & chills

Risk Factors

  • Obesity
  • Diabetes mellitus & malignancy
  • Immunocompromise
  • Previous cutaneous damage
  • Edema from venous insufficiency or lymphatic obstruction
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.